Tarragona, Spain

Jordi Cerón Bertran


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jordi Cerón Bertran

Introduction

Jordi Cerón Bertran is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of compounds. With a total of 2 patents, his work has implications for drug formulation and delivery.

Latest Patents

One of his latest patents is for a monoclinic crystalline form of asenapine maleate with a specific particle size distribution. This invention is characterized by its non-micronized form and a particle size distribution with a d90 of 40 µm or less. The process for preparing this form involves mixing monoclinic asenapine maleate with an organic solvent, stirring at controlled temperatures, and collecting the resulting crystals.

Another significant patent is for a new polymorphic form of arformoterol tartrate, designated as form D. This form is characterized by a unique powder X-ray diffraction pattern and a specific DSC thermogram. The invention also includes processes for preparing this new polymorphic form and its potential uses in therapeutic applications.

Career Highlights

Jordi Cerón Bertran is currently associated with Laboratorios Lesvi, S.L., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds through novel crystalline forms.

Collaborations

He collaborates with esteemed colleagues such as Glòria Freixas Pascual and Lluis Solà Carandell, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jordi Cerón Bertran's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to advancing drug formulation technologies. His innovative work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…